Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

Study decodes combinatorial p53 modification networks

12

Nov 2026

Study decodes combinatorial p53 modification networks

A recent review highlights that p53 activity is orchestrated by a combinatorial network of post-translational modifications (PTMs), in which writers, erasers and reader proteins dynamically shape protein stability, DNA binding, subcellular localization, co-regulator assembly and transcriptional output.

Type 2 diabetes accelerates jawbone loss and causes tooth loss

11

Nov 2026

Type 2 diabetes accelerates jawbone loss and causes tooth loss

Type 2 diabetes (T2D) is a chronic metabolic disorder whose global burden continues to rise. Beyond its systemic effects, T2D compromises skeletal health and markedly worsens loss of alveolar bone—the bone that anchors teeth—leading to tooth loosening, increased mobility, and eventual tooth loss.

UK food labels fail to flag most ultra-processed products

11

Nov 2026

UK food labels fail to flag most ultra-processed products

The study, published in BMJ Medicine, found that among the official public health definitions used to identify and regulate food and drink products in the UK, each varied widely in what proportion of processed and ultra-processed products was classed as unhealthy, while systems such as traffic light labels failed to identify more than half of these unhealthy packaged foods.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.